Results 371 to 380 of about 425,993 (391)
Some of the next articles are maybe not open access.
HCV-related autoimmune and neoplastic disorders: the HCV syndrome
Digestive and Liver Disease, 2007Hepatitis C virus (HCV) chronic infection may be associated with a great number of both hepatic and extrahepatic manifestations. HCV lymphotropism is responsible for poly-oligoclonal B-lymphocyte expansion, which is the common underlying alteration in a significant percentage of HCV-infected individuals.
FERRI, Clodoveo +7 more
openaire +7 more sources
HCV-specific lymphocyte responses in individuals with positive anti-HCV but negative HCV-RNA
Journal of Clinical Virology, 2015Hepatitis C virus (HCV) status cannot be reliably predicted in anti-HCV positive/HCV-RNA negative individuals who may either have recovered spontaneously or have a false-positive test due to antibody cross-reaction. Investigating T lymphocyte responses in individuals with different HCV status may help understand the cellular immune mechanisms ...
Sili, Uluhan +7 more
openaire +4 more sources
HCV-related autoimmune disorders in HCV chronic infection.
La Clinica terapeutica, 2013Patients with hepatitis C virus (HCV) chronic infection may develop a great number of extrahepatic manifestations. Among these latter, mixed cryoglobulinemia (MC) represents the prototype of HCV-associated autoimmune-lymphoproliferative disorders. Other rheumatological manifestations of HCV chronic infection are Siögren syndrome, arthritis and CREST ...
Ferrari S. M. +6 more
openaire +5 more sources
Current Pharmaceutical Design, 2008
It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C virus (HCV). According to data from WHO community and blood donor surveys, the African and Eastern Mediterranean countries report the highest prevalence rates (>10%).
BALDO, VINCENZO +3 more
openaire +4 more sources
It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C virus (HCV). According to data from WHO community and blood donor surveys, the African and Eastern Mediterranean countries report the highest prevalence rates (>10%).
BALDO, VINCENZO +3 more
openaire +4 more sources
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
Nature Immunology, 2021N. Hensel +20 more
semanticscholar +1 more source
Current epidemiology of HCV in Sicily: the RESIST-HCV model
Digestive and Liver Disease, 2019Background: Real-world data to guide hepatitis C virus (HCV)- related public health initiatives and linkage to care of patients are lacking in our region. Aims: To describe the epidemiological features of a large cohort of patients with chronic HCV infection from Sicily included in a regional network aimed at DAA treatment (RESIST-HCV).
Di Marco, V +17 more
openaire +3 more sources
Archives of Medical Research, 2000
Hepatitis C virus (HCV) infection is one of the most prevalent infectious diseases in the world. In 1997, hepatitis C became a statutorily noticeable disease in Poland. Nevertheless, to date, only a few notable studies on the prevalence of HCV infection have been carried out in Poland.
Krzysztof P. Bielawski +3 more
openaire +3 more sources
Hepatitis C virus (HCV) infection is one of the most prevalent infectious diseases in the world. In 1997, hepatitis C became a statutorily noticeable disease in Poland. Nevertheless, to date, only a few notable studies on the prevalence of HCV infection have been carried out in Poland.
Krzysztof P. Bielawski +3 more
openaire +3 more sources
The HCV-bDNA probe method for measurement of HCV-RNA counts by HCV genotype
International Hepatology Communications, 1994Abstract HCV-RNA counts have been determined previously by using the reverse transcription (RT)-competitive polymerase chain reaction (PCR) method. Recently, the HCV-branched DNA (HCV-bDNA) probe method, an application of hybridization technology, was developed, and it made an easy measurement of HCV-RNA counts possible.
openaire +2 more sources
Reviews in clinical and experimental hematology, 2003
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo +3 more
openaire +4 more sources
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo +3 more
openaire +4 more sources

